Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.
Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (2)
- Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry 2026-09-01 · Expand citations
- Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols 2026-04-01 · Expand citations